Whole Genome-Based Liquid Biopsy Assay Commercialization, Collaboration CommencesÂ
Personalis, Inc. has partnered with Tempus to commercialize NeXT Personal, an ultra-sensitive, whole genome-based liquid biopsy assay.
Category: Immunoassay Reagents & test Kits
Immunoassay Reagents & test Kits
Latest
Immunoassay Reagents & test Kits
Latest
Absolute Biotech Relaunches SCICONS dsRNA Antibodies and ELISA Kits
Absolute Biotech, a company uniting multiple antibody-centric brands into a single organization, is reintroducing SCICONS dsRNA antibodies.Â
Immunoassay Reagents & test Kits
Latest
BD, CerTest Biotec Mpox Test Gets Emergency Use Authorization
BD and CerTest Biotec have announced EUA from the U.S. Food and Drug Administration (FDA) for a molecular PCR assay for Mpox virus detection.
Monkeypox Diagnostic Testing Launched by US BioTek
US BioTek Laboratories is now offering Monkeypox Diagnostic Testing, utilizing a lesion swap specimen and RT-PCR testing.
Read More
FDA Authorizes Quest Diagnostics’ Monkeypox Test for Emergency Use
Quest Diagnostics received emergency use authorization (EUA) from the U.S. FDA for it’s lab-developed Monkeypox virus test.
Read More
Immunoassay Tech Developer Unveils SARS-CoV-2 Neutralizing Antibody Test Kit
Protein detection platform developer, Spear Bio, unveiled its first product to market: the NAB-Sure SARS-CoV-2 neutralizing antibody test kit.
Read More
Siemens Healthineers Brings Millions of Rapid COVID Tests to Market
R.R. Donnelley & Sons Co., a supply chain solutions provider, supported Siemens Healthineers to accelerate delivery of rapid COVID self-tests.
Read More
MicroGEM & Medline Partner to Equip Healthcare Providers with Saliva Point-of-Care PCR Tests
MicroGEM announced that Medline is now offering the MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test.
Read More
Spear Bio’s NAB-Sure Test Kit Aids Analysis of COVID Immune Response
The NAB-Sure SARS-CoV-2 Neutralizing Antibody Test Kit helps researchers better understand COVID immune response and validate vaccines.
Read More
GenScript Responds to Monkeypox Health Emergency with Real-Time PCR Test
GenScript USA, a subsidiary of GenScript Biotech Corp., announced the immediate availability of a monkeypox virus PCR test kit.
Read More
FDA Approves VENTANA MMR RxDx Panel
The U.S. Food and Drug Administration (FDA) has approved a label expansion for Roche’s VENTANA MMR RxDx Panel.
Read More
Meridian’s SARS-CoV-2 Molecular Assay Gets FDA Re-Authorization
Meridian Bioscience received re-authorization from the FDA of its Emergency Use Authorization (EUA) for a SARS-COV-2 molecular assay.
Read More
BD, CerTest Biotec Unveil Commercial Launch of Monkeypox Test
BD and CerTest Biotec announced their newly developed molecular PCR test for the monkeypox virus is commercially available outside the U.S.
Read More
ARUP’s Monkeypox Test Works on High-Throughput Instruments
ARUP Laboratories has begun in-house testing for the monkeypox virus with its Orthopoxvirus by RT-PCR test.
Read More
BD Launches Combo Test for SARS-CoV-2, Influenza & Respiratory Syncytial Virus
The BD MAX Respiratory Viral Panel is a diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV).
Read More
Seegene Develops PCR Test to Detect Monkeypox Virus
Seegene, a molecular diagnostics (MDx) company, has developed a PCR test designed to detect the monkeypox virus.
Read More
Co-Diagnostics Completes Principal Design of Monkeypox Virus Test
Co-Diagnostics completed the principal design work of a PCR test for the monkeypox virus, which is exhibiting a multi-country outbreak.
Read More
Seegene Unveils COVID Testing Initiative to Help End Pandemic
Seegene unveiled a global initiative for preemptive and routine PCR COVID-19 testing to help individuals stay healthy during the pandemic.
Read More